Treatment for Malaria
For uncomplicated P. falciparum malaria, treat with oral artemisinin-based combination therapy (ACT), specifically artemether-lumefantrine or dihydroartemisinin-piperaquine; for severe malaria, immediately administer intravenous artesunate. 1
Uncomplicated Malaria Treatment
P. falciparum (Most Common in Travelers from Africa)
First-line treatment is oral ACT 1:
- Artemether-lumefantrine (AL) - most commonly used
- Dihydroartemisinin-piperaquine (DHA-PPQ) - superior efficacy for preventing recurrence
- Both are now endorsed by WHO for use in all trimesters of pregnancy 1
Second-line alternatives when ACTs contraindicated (QT prolongation risk) 1:
- Atovaquone-proguanil
- Quinine sulfate + doxycycline/clindamycin
Critical geographic consideration: For patients from Southeast Asia (Greater Mekong sub-region), use atovaquone-proguanil as first-line due to high ACT resistance rates 1
Important caveat: Swiss guidelines recommend extending AL treatment from 3 to 5 days due to treatment failures related to body weight affecting lumefantrine concentrations 1. Monitor for post-artemisinin delayed hemolysis (PADH) - occurs in 37.4% of patients by day 14, requiring follow-up complete blood counts 1.
P. vivax, P. ovale, P. malariae
Chloroquine remains the drug of choice (25 mg base/kg total dose over 3 days) 1
Exception: Use ACT for travelers from Papua New Guinea, Indonesia, and Sabah where chloroquine resistance exceeds 10% 1
Mandatory additional treatment for P. vivax and P. ovale: Add primaquine or tafenoquine to eliminate liver hypnozoites and prevent relapse 1. Must check G6PD status before administering 8-aminoquinolines for radical cure 2.
Severe Malaria Treatment
Intravenous artesunate is the only first-line therapy for severe malaria 1, 3
Criteria for Severe Malaria (WHO)
- Impaired consciousness/coma
- Respiratory distress/pulmonary edema
- Shock
- Seizures
- Significant bleeding
- Jaundice
- Severe anemia
- Renal impairment
- Acidosis
- Hypoglycemia
- High parasitemia (>5% in non-immune patients)
- Hyperlactatemia
Management approach 1:
- Admit to intensive care unit
- Check parasitemia every 12 hours until <1%, then every 24 hours until negative
- Daily monitoring: complete blood count, hepatic/renal function, glucose, blood gas
- Monitor for delayed hemolysis for 4 weeks post-treatment 4
Common Pitfalls
Thrombocytopenia alone is NOT a criterion for severe malaria - this is the most common reason for inappropriate artesunate overuse in non-severe cases 5. Do not escalate to parenteral therapy based solely on low platelet counts.
Do not delay treatment for diagnostic confirmation in suspected severe cases - begin treatment immediately if testing not immediately available 2
Chloroquine is no longer appropriate for P. falciparum from most regions due to widespread resistance, except Haiti and limited Central American areas 3